Vree Health: Reduce Readmissions with Patient Engagement
President Kyle Dolbow of Vree Health shares exclusive first look at patient support care.
New York, NY- Kyle Dolbow, President of Merck owned Vree Health, interviews with eyeforpharma, releasing first hand insight to new program Transition Advantage.
Dolbow and Vree Health believe that using the right combination of technology and human contact will lead to better outcomes, and that hospitals and healthcare providers must stress value beyond the pill to lead to superior patient satisfaction and health outcomes.
Dolbow states, “Transition Advantage is about people, process, and technology. It’s not a pure technology solution. What we want is to ground the interaction with the patient’s personal goals. That’s part of being patient-centric. We want to help the patient achieve their personal recovery goals.”
Vree Health is a wholly owned subsidiary of Merck and operates with their principles and legacy in mind, focusing on value beyond the pill, and the balance betweenbusiness & high quality patient care at all times. The Transition Advantage service is designed to save money and satisfy patients. “One of the principles that Merck pharmaceuticals was founded on was that if you take care of the patient, your business will thrive” says Dolbow, showing the importance of customer service and care.
Improving customer care is essential amongst success in competing hospitals and health care providers. Dolbow says, “When you look at outcomes focused health care, the interests of all parties are lined up, payers, providers, and of course, the patient. What you will see in the future is new alliances to affect patient results. I think the way the new models will succeed is through ecosystems that are acting together to improve the care. “
Kyle Dolbow will be joining numerous executives at the eyeforpharma Philadelphia conference on April 15th & 16th, where he will present this case study and give more insight on patient centricity plans. For more information on eyeforpharma Philadelphia hosted at the Sheraton Downtown Philadelphia please click here: www.eyeforpharma.com/philadelphia/
For more information contact:
Brittany Reyes
Global Marketing Director
eyeforpharma
Telephone: 201-234-4755
Email:breyes@eyeforpharma.com